L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial - Giordano, Frank Anton; Layer, Julian; Leonardelli, Sonia; Friker, Lea L.; Turiello, Roberta; Corvino, Dillon; Zeyen, Thomas; Schaub, Christina; Müller, Wolf; Sperk, Elena; Schmeel, Christopher; Sahm, Katharina; et al. (Nature Communications, 2024)
Gesehen am 19.12.2024